vs

Side-by-side financial comparison of CITY HOLDING CO (CHCO) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

CITY HOLDING CO is the larger business by last-quarter revenue ($80.2M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.8%). CITY HOLDING CO produced more free cash flow last quarter ($128.4M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.3%).

Jam City, Inc. is an American video game developer and publisher based in Culver City, California. The company was founded in 2010 by Chris DeWolfe, Colin Digiaro, Aber Whitcomb, and Josh Yguado. Jam City has nine studios located in the United States, Canada, South America, and Europe. As of 2021, it employs 825 people. Netmarble is the largest shareholder in Jam City. As of 2021, Jam City's games have 31 million monthly active users and 1.3 billion total downloads.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

CHCO vs PBYI — Head-to-Head

Bigger by revenue
CHCO
CHCO
1.1× larger
CHCO
$80.2M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+15.9% gap
PBYI
27.7%
11.8%
CHCO
More free cash flow
CHCO
CHCO
$114.1M more FCF
CHCO
$128.4M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
5.3%
CHCO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCO
CHCO
PBYI
PBYI
Revenue
$80.2M
$75.5M
Net Profit
$31.6M
Gross Margin
69.3%
Operating Margin
49.3%
22.7%
Net Margin
39.4%
Revenue YoY
11.8%
27.7%
Net Profit YoY
10.2%
EPS (diluted)
$2.17
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCO
CHCO
PBYI
PBYI
Q4 25
$80.2M
$75.5M
Q3 25
$81.3M
$54.5M
Q2 25
$78.2M
$52.4M
Q1 25
$74.6M
$46.0M
Q4 24
$71.7M
$59.1M
Q3 24
$76.0M
$80.5M
Q2 24
$73.5M
$47.1M
Q1 24
$72.4M
$43.8M
Net Profit
CHCO
CHCO
PBYI
PBYI
Q4 25
$31.6M
Q3 25
$35.2M
$8.8M
Q2 25
$33.4M
$5.9M
Q1 25
$30.3M
$3.0M
Q4 24
$28.7M
Q3 24
$29.8M
$20.3M
Q2 24
$29.1M
$-4.5M
Q1 24
$29.5M
$-4.8M
Gross Margin
CHCO
CHCO
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
CHCO
CHCO
PBYI
PBYI
Q4 25
49.3%
22.7%
Q3 25
54.0%
17.6%
Q2 25
52.7%
12.7%
Q1 25
49.5%
8.7%
Q4 24
48.1%
22.6%
Q3 24
48.9%
27.4%
Q2 24
49.3%
-4.6%
Q1 24
50.6%
-5.3%
Net Margin
CHCO
CHCO
PBYI
PBYI
Q4 25
39.4%
Q3 25
43.3%
16.2%
Q2 25
42.7%
11.2%
Q1 25
40.7%
6.5%
Q4 24
40.0%
Q3 24
39.2%
25.2%
Q2 24
39.6%
-9.6%
Q1 24
40.8%
-11.0%
EPS (diluted)
CHCO
CHCO
PBYI
PBYI
Q4 25
$2.17
$0.26
Q3 25
$2.41
$0.17
Q2 25
$2.29
$0.12
Q1 25
$2.06
$0.06
Q4 24
$1.94
$0.40
Q3 24
$2.02
$0.41
Q2 24
$1.96
$-0.09
Q1 24
$1.97
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCO
CHCO
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$191.9M
$97.5M
Total DebtLower is stronger
$150.0M
$22.7M
Stockholders' EquityBook value
$809.7M
$130.3M
Total Assets
$6.7B
$216.3M
Debt / EquityLower = less leverage
0.19×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCO
CHCO
PBYI
PBYI
Q4 25
$191.9M
$97.5M
Q3 25
$225.6M
$94.4M
Q2 25
$172.1M
$96.0M
Q1 25
$384.7M
$93.2M
Q4 24
$225.4M
$101.0M
Q3 24
$293.9M
$96.7M
Q2 24
$218.0M
$96.8M
Q1 24
$318.7M
$107.2M
Total Debt
CHCO
CHCO
PBYI
PBYI
Q4 25
$150.0M
$22.7M
Q3 25
$150.0M
$34.0M
Q2 25
$150.0M
$45.3M
Q1 25
$150.0M
$56.7M
Q4 24
$150.0M
$68.0M
Q3 24
$150.0M
$79.3M
Q2 24
$150.0M
$90.7M
Q1 24
$150.0M
$102.0M
Stockholders' Equity
CHCO
CHCO
PBYI
PBYI
Q4 25
$809.7M
$130.3M
Q3 25
$798.9M
$115.3M
Q2 25
$764.2M
$104.7M
Q1 25
$756.3M
$97.1M
Q4 24
$730.7M
$92.1M
Q3 24
$741.3M
$71.1M
Q2 24
$686.7M
$48.5M
Q1 24
$682.2M
$51.0M
Total Assets
CHCO
CHCO
PBYI
PBYI
Q4 25
$6.7B
$216.3M
Q3 25
$6.7B
$202.9M
Q2 25
$6.6B
$194.9M
Q1 25
$6.6B
$196.2M
Q4 24
$6.5B
$213.3M
Q3 24
$6.4B
$220.7M
Q2 24
$6.3B
$205.0M
Q1 24
$6.3B
$214.1M
Debt / Equity
CHCO
CHCO
PBYI
PBYI
Q4 25
0.19×
0.17×
Q3 25
0.19×
0.30×
Q2 25
0.20×
0.43×
Q1 25
0.20×
0.58×
Q4 24
0.21×
0.74×
Q3 24
0.20×
1.12×
Q2 24
0.22×
1.87×
Q1 24
0.22×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCO
CHCO
PBYI
PBYI
Operating Cash FlowLast quarter
$131.4M
$14.4M
Free Cash FlowOCF − Capex
$128.4M
$14.4M
FCF MarginFCF / Revenue
160.2%
19.1%
Capex IntensityCapex / Revenue
3.6%
0.0%
Cash ConversionOCF / Net Profit
4.16×
TTM Free Cash FlowTrailing 4 quarters
$223.3M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCO
CHCO
PBYI
PBYI
Q4 25
$131.4M
$14.4M
Q3 25
$37.3M
$9.7M
Q2 25
$28.2M
$14.1M
Q1 25
$31.5M
$3.6M
Q4 24
$131.9M
$15.6M
Q3 24
$37.6M
$11.0M
Q2 24
$28.3M
$1.0M
Q1 24
$32.2M
$11.2M
Free Cash Flow
CHCO
CHCO
PBYI
PBYI
Q4 25
$128.4M
$14.4M
Q3 25
$35.8M
$9.7M
Q2 25
$27.8M
$14.1M
Q1 25
$31.3M
$3.6M
Q4 24
$129.2M
$15.6M
Q3 24
$37.0M
$11.0M
Q2 24
$27.8M
$1.0M
Q1 24
$31.6M
FCF Margin
CHCO
CHCO
PBYI
PBYI
Q4 25
160.2%
19.1%
Q3 25
44.0%
17.7%
Q2 25
35.6%
26.8%
Q1 25
41.9%
7.7%
Q4 24
180.2%
26.4%
Q3 24
48.7%
13.7%
Q2 24
37.8%
2.1%
Q1 24
43.6%
Capex Intensity
CHCO
CHCO
PBYI
PBYI
Q4 25
3.6%
0.0%
Q3 25
1.9%
0.0%
Q2 25
0.5%
0.0%
Q1 25
0.3%
0.1%
Q4 24
3.8%
0.0%
Q3 24
0.9%
0.0%
Q2 24
0.7%
0.0%
Q1 24
0.8%
0.0%
Cash Conversion
CHCO
CHCO
PBYI
PBYI
Q4 25
4.16×
Q3 25
1.06×
1.10×
Q2 25
0.85×
2.41×
Q1 25
1.04×
1.21×
Q4 24
4.60×
Q3 24
1.26×
0.54×
Q2 24
0.97×
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons